Alfa Laval AB (0NNF)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 554.00 |
|---|---|
| 52-week range | 426.60 – 594.40 |
| Return, 1 month / 3 months | −2.1% / −2.4% |
| Return, 1 year / 3 years | +19.3% / +62.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 22.1% |
| Worst drawdown (1 year) | -9.2% |
| Average daily value traded | 74.76M SEK |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alfa Laval is a Swedish industrial company based in Lund that builds equipment for processing and treating liquids and gases. Its main products include heat exchangers, centrifugal separators, pumps, valves and tank cleaning systems. Customers come from shipping, energy, food and beverage production, pharmaceuticals and water treatment, where the equipment is used to heat, cool, separate and move fluids. The company also provides related service and maintenance work for installed equipment around the world.
On this site Alfa Laval AB appears as a stock on the London Stock Exchange (UK), code 0NNF, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alfa Laval AB (0NNF) trades on the London Stock Exchange in UK. It last closed at SEK 554.00 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 598 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.3% and over the last three months it fell 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.3% | ||
| From 52-week high | -6.1% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.4% | ||
| 6-month return | 2.3% | ||
| 12-month return, skipping the last month | 21.8% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.2% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 74.76M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −2.1% |
| 3 months | −2.4% |
| 6 months | +2.3% |
| 1 year | +19.3% |
| 3 years | +62.6% |
| 5 years | +70.7% |
Signals
| 50-day / 200-day average | 560.64 / 541.40 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | SEK 9.0000 |
| 30 Apr 2025 | SEK 8.5000 |
| 26 Apr 2024 | SEK 7.5000 |
| 26 Apr 2023 | SEK 6.0000 |
| 27 Apr 2022 | SEK 6.0000 |
| 28 Apr 2021 | SEK 5.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.